Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Schizophrenia

S R Marder1, D Ames, W C Wirshing

  • 1West Los Angeles Veterans Administration Medical Center, Brentwood Division, California.

The Psychiatric Clinics of North America
|September 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.

The journal of prevention of Alzheimer's disease·2019
Same author

Genetic and Environmental Influences on Language Ability in Older Adults: Findings from the Older Australian Twins Study.

Behavior genetics·2018
Same author

Childhood adversity and cognitive function in schizophrenia spectrum disorders and healthy controls: evidence for an association between neglect and social cognition.

Psychological medicine·2017
Same author

Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder.

Translational psychiatry·2017
Same author

Dietary Supplement Use in Older People Attending Memory Clinics in Australia.

The journal of nutrition, health & aging·2016
Same author

Repurposing Drugs for Cognition in Schizophrenia.

Clinical pharmacology and therapeutics·2016
Same journal

Digital Mental Health: Progress but not Perfection.

The Psychiatric clinics of North America·2026
Same journal

Advances in Mental Health Technology.

The Psychiatric clinics of North America·2026
Same journal

The Future of Digital Mental Health: A Literature Review.

The Psychiatric clinics of North America·2026
Same journal

Assessment and Treatment of Posttraumatic Stress Disorder via Digital Mental Health Technology.

The Psychiatric clinics of North America·2026
Same journal

Treatment of Obsessive-Compulsive Disorder via Mental Health Technology.

The Psychiatric clinics of North America·2026
Same journal

Digital Mental Health Treatments for Depression.

The Psychiatric clinics of North America·2026
See all related articles

Schizophrenia treatment has seen little change, but clozapine offers improved efficacy and safety over conventional antipsychotics. This discovery paves the way for better biologic therapies for schizophrenia patients.

Area of Science:

  • Neuropharmacology
  • Psychiatry
  • Clinical Medicine

Background:

  • Pharmacologic treatment for schizophrenia has stagnated for 35 years.
  • The hyperdopaminergic hypothesis of schizophrenia may be an oversimplification.
  • Conventional antipsychotics have limited efficacy and significant side effects, leading to poor patient compliance.

Purpose of the Study:

  • To review the evolution of antipsychotic pharmacotherapy.
  • To highlight the limitations of conventional neuroleptics.
  • To introduce clozapine as a novel therapeutic agent with improved properties.

Main Methods:

  • Review of existing literature on schizophrenia pharmacotherapy.
  • Comparative analysis of conventional neuroleptics and clozapine.

Related Experiment Videos

  • Discussion of neuropharmacological advancements.

    • Main Results:

    • Conventional neuroleptics demonstrate partial efficacy and considerable side effects.
    • Clozapine exhibits superior efficacy and reduced neurotoxicity compared to older antipsychotics.
    • This challenges the long-held belief in uniform efficacy and neurotoxicity of antipsychotics.

    Conclusions:

    • Clozapine represents a significant advancement in schizophrenia treatment.
    • Future biologic therapies may offer safer and more effective options.
    • The legacy of clozapine encourages the development of improved antipsychotic medications.